NCT04007302

Brief Summary

The hypothesis of this work is that distraction is an effective way to modify the feeling and experience of chronic lumbar pain by modifying the functioning of the prefrontal cortex. The main objective of this study is to show that during chronic low back pain generated during physical exercise, virtual reality distraction leads to the modification of the activity of the prefrontal cortex. The secondary objectives are:

  • Show a significant decrease in the average pain assessed with EVA during physical exercise with virtual reality distraction.
  • Show an increase in the distance travelled with virtual reality distraction.
  • Observe a decrease in perceived effort with virtual reality distraction.
  • Quantify the adherence (presence) of subjects to the virtual environment

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 3, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
Last Updated

July 8, 2019

Status Verified

July 1, 2019

Enrollment Period

2 months

First QC Date

July 1, 2019

Last Update Submit

July 3, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • measurement of prefrontal cortex activity

    Brain oxygenation responses will be measured by the use of the Near Infrared Spectroscopy (NIRS) method (µmolar\*cm)

    Day 1

  • measurement of prefrontal cortex activity

    Brain oxygenation responses will be measured by the use of the Near Infrared Spectroscopy (NIRS) method (µmolar\*cm)

    Day 2

Secondary Outcomes (11)

  • assessment of average pain

    Inclusion

  • assessment of average pain

    Day 1

  • assessment of average pain

    Day 2

  • measurement of the distance travelled

    Inclusion

  • measurement of the distance travelled

    Day 1

  • +6 more secondary outcomes

Study Arms (2)

walking with distraction

EXPERIMENTAL

the patient walks in front of a screen with virtual reality simulation

Other: measurement of bilateral activity of the prefrontal cortex by a NIRS system (near infrared spectroscopy)Other: completion of questionnairesOther: completion of questionnaires for pain

Walking without distraction

ACTIVE COMPARATOR

the patient walks on a treadmill without virtual reality simulation

Other: measurement of bilateral activity of the prefrontal cortex by a NIRS system (near infrared spectroscopy)Other: completion of questionnairesOther: completion of questionnaires for pain

Interventions

measurement of the cerebral oxygenation response by the use of the Near Infrared Spectroscopy (NIRS) method

Walking without distractionwalking with distraction

igroup presence questionnaire (IPQ), Dallas Pain Questionnaire (DRAD), Fear-Avoidance Beliefs (FABQ) and Quebec Back Lumbago Scale

Walking without distractionwalking with distraction

analogical visual and numerical scale and Borg scale

Walking without distractionwalking with distraction

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient must have given free and informed consent and signed the consent
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is available for a 3-day follow-up
  • The patient is between 18 and 75 years old
  • Disabling lumbar pain beyond three months

You may not qualify if:

  • Subject participates in another intervention study
  • The subject is under the protection of justice, guardianship or curatorship
  • Subject refuses to sign consent
  • It is impossible to provide informed information about the subject
  • The subject is unable to complete the study questionnaires
  • The patient is pregnant, parturient, or breastfeeding
  • The subject has a contraindication (or incompatible drug combination) for a treatment required for this study
  • Recent involuntary weight loss
  • Inflammatory schedule pain (predominantly nocturnal, requiring early morning rusting, improved by physical activity)
  • Associated fever,
  • Saddle anaesthesia
  • Vesico-sphincterial disorders
  • Typical root symptoms
  • Systemic corticosteroid therapy
  • History of cancer
  • +5 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes

Nîmes, 30129, France

Location

MeSH Terms

Conditions

Low Back Pain

Interventions

Spectroscopy, Near-Infrared

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisSpectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Anissa MEGZARI

    Centre Hospitalier Universitaire de Nīmes

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2019

First Posted

July 5, 2019

Study Start

September 9, 2018

Primary Completion

November 3, 2018

Study Completion

November 3, 2018

Last Updated

July 8, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations